Cimetidine 800mg tablets

Country: যুক্তরাজ্য

ভাষা: ইংরেজি

সূত্র: MHRA (Medicines & Healthcare Products Regulatory Agency)

সক্রিয় উপাদান:

Cimetidine

থেকে পাওয়া:

Tillomed Laboratories Ltd

এটিসি কোড:

A02BA01

INN (International Name):

Cimetidine

ডোজ:

800mg

ফার্মাসিউটিকাল ফর্ম:

Oral tablet

প্রশাসন রুট:

Oral

শ্রেণী:

No Controlled Drug Status

প্রেসক্রিপশন টাইপ:

Valid as a prescribable product

পণ্য সারাংশ:

BNF: 01030100; GTIN: 5024655000937

তথ্য লিফলেট

PACKAGE LEAFLET: INFORMATION FOR THE USER
CIMETIDINE 200 MG, 400 MG & 800 MG TABLETS
(CIMETIDINE)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor or pharmacist.
•
This medicine has been prescribed for you only. Do not pass it on to
others.
It may harm them, even if their symptoms are the same as yours.
•
If you get any side effects, talk to your doctor or pharmacist. This
includes any
possible side effects not listed in this leaflet. See section 4.
IN THIS LEAFLET:
1. WHAT CIMETIDINE TABLETS ARE AND WHAT THEY ARE USED FOR
2. BEFORE YOU TAKE CIMETIDINE TABLETS
3. HOW TO TAKE CIMETIDINE TABLETS
4. POSSIBLE SIDE EFFECTS
5. HOW TO STORE CIMETIDINE TABLETS
6. CONTENTS OF THE PACK AND OTHER INFORMATION
1.
WHAT CIMETIDINE TABLETS ARE AND WHAT THEY ARE USED FOR
The name of your medicine is Cimetidine Tablets. It contains the
active ingredient
called Cimetidine. Cimetidine belongs to a group of medicines called
Histamine
H2 - receptor antagonists and is used as anti-ulcer drug. It works by
reducing the
amount of acid in your stomach.
The tablets are used to treat and relieve the following conditions:
•
Ulcers in the stomach (gastric ulcer) and in upper part of the
intestine
(duodenum ulcer)
•
Recurrent or stomach ulcers (ulcers that keep coming back or which
have
occurred following stomach surgery).
•
Ulcers in the stomach or duodenum which may be caused by non-steroidal
anti-inflammatory drugs (NSAIDs, often used to reduce pain, fever and
inflammation)
•
Acid from the stomach escaping into the food pipe causing pain,
inflammation
and heartburn (oesophageal reflux).
•
Persistent heartburn and stomach pain.
•
Upper abdominal pain particularly after meals
•
Prevent of internal bleeding from ulcers caused by stress in seriously
ill patients.
•
For patients at risk of acid inhalation before general anaesthesia
particularly
pregnant women during labour (Mendelson's syndrome)

পণ্য বৈশিষ্ট্য

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Cimetidine 800 mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 800 mg cimetidine.
For the full list of excipients, see section 6.1
3
PHARMACEUTICAL FORM
Film-coated tablet.
A pale green, oval, convex, scored, film-coated tablet with an
approximate
size of 9.6mm x 19mm, coded CIM 800 on one side
The score line is not intended for breaking the tablet
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Cimetidine is a histamine H
2
-receptor antagonist which rapidly inhibits both
basal and stimulated gastric secretion of acid and reduces pepsin
output.
Cimetidine
is
indicated
in
the
treatment
of
duodenal
or
benign
gastric
ulceration,
including
that
associated
with
non-steroidal
anti-inflammatory
agents,
recurrent
and
stomal
ulceration.
Reflux
eosophagitis
and
other
conditions where reduction of gastric acid by Cimetidine has been
shown to be
beneficial:
persistent
dyspeptic
symptoms
with
or
without
ulceration,
particularly meal-related upper abdominal pain, including such
symptoms
associated
with
non-steroidal
anti-inflammatory
agents.
Zollinger-Ellison
syndrome. Prophylaxis of stress ulceration in seriously acutely ill
patients.
Prophylaxis of acid aspiration syndrome and before general anaesthesia
in
patients thought to be at risk of acid aspiration (Mendelson's
Syndrome),
particularly obstetric patients during labour; to reduce malabsorption
and fluid
loss in the short bowel syndrome; and in pancreatic insufficiency to
reduce
degradation of enzyme supplements.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
POSOLOGY
The total daily dose by any route should not normally exceed 2.4g.
Dosage
should be reduced in patients with impaired renal function (see
Special
warnings and precautions for use)
_ADULTS _
For patients with duodenal or benign gastric ulceration, a single
daily dose of
800 mg at bedtime is recommended. Otherwise the usual dosage is 400 mg
twice a day with breakfast and at bedtime. Other effective regimens
are 200
mg